The development of resistance to anthelmintics: A perspective with an emphasis on the antischistosomal drug praziquantel

Experimental Parasitology

Volumn 87, Issue 3, 1997, Pages 260-267

  Bennett, James L ^a,d   Day, Tim ^a   Feng Tao, Liang ^b   Ismail, Magdi ^c   Farghaly, Adel ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^c ZAGAZIG UNIVERSITY   (Egypt)

^d Keystone Symposia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

DRUG RESISTANCE; HELMINTH; HUMAN; INFECTION CONTROL; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA; SCHISTOSOMIASIS; SHORT SURVEY;

SCHISTOSOMA; VERMES;

EID: 0031282472     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1997.4229     Document Type: Article

References (25)

1. Andrews, P., and Thomas, H. 1983. Praziquantel. Medicinal Research Review 3, 147-200.
2. Brindley, P. 1994. Drug resistance to schistosomicides and other anthelmintics of medical significance. Acta Tropical 56, 213-221.
3. Brindley, P. J., Stand, M., Norden, A., and Sher, A. 1989. Role of host antibody in the chemotherapeutic action of praziquantel against S. mansoni. Molecular and Biochemical Parasitology 34, 99-108.
4. Cioli, D., Pica-Mattoccia, L., and Moroni, R. 1992. S. mansoni: Hycanthone/oxamiquine resistance is controlled by a single autosomal recessive gene. Experimental Parasitology 75, 425-432.
5. Cioli, D., Pica-Mattoccia, L., and Archer, S. 1993. Drug resistance in schistosomes. Parasitology Today 9, 162-168.
6. Day, T., Bennett, J. L., and Pax, R. A. 1992. Praziquantel: The enigmatic antiparasitic. Parasitology Today 8, 343-344.
7. Fallon, P., and Doenhoff, M. F. 1994. Drug-resistance schistosomiasis: resistance to praziquantel and oxaminquine induced in S. mansoni in mice is drug specific. American Journal Tropical Medicine and Hygiene 51, 83-88.
8. Fallon, P. G., Sturrock, R. F., Capron, A., Niang, M., and Doenhoff, M. J. 1995. Short report: Diminished susceptibility to praziquantel in a Sengal isolate of S. mansoni. American Journal Tropical Medicine Hygiene 53, 61-62.
9. Fallon, P., Tao, F-F., Ismail, M. M., and Bennett, J. L. 1996. Schistosome resistance to praziquantel: Fact or artifact. Parasitology Today 12, 316-320.
10. Gasser, R. B., Baozhen, Q., Nansen, P., Johansen, M. V., and Bogh, H. 1996. Use of RAPD for the detection of genetic variation in the human blood fluke, Schistosoma japonicum, from mainland China. Molecular and Cellular Probes 10, 353-358.
11. Grant, W. 1994. Genetic variation in parasitic nematodes and its implications. International Journal Parasitology 24, 821-830.
12. Gryseels, B. 1994. Epidemiology, immunology and chemotherapy of S. mansoni infectionfvs in a recently exposed community in Senegal. Tropical and Geographic Medicine 46, 209-219.
13. Ismail, M., Metwally, A., Farghly, A., Bruce, J., Tao, L. F., and Bennett, J. L. 1996. Characterization of isolates of S. mansoni from Egyptian villagers that tolerate high doses of praziquantel. American Journal Tropical Medicine and Hygiene 55, 214-218.
14. Jackson, F. 1993. Anthelmintic resistance: The state of play. British Veterinary Journal 149, 123-138.
15. Katz, N. 1980. Susceptibility to chemotherapeutic agents of strains of S. mansoni isolated from treated and untreated patients. American Journal Tropical Medicine 29, 890-894.
16. Kuman, V., and Gryseels, B. 1994. Use of praziquantel against schistosomiasis: A review of current status. Int. J. Antimicrobiol Agents 4(4), 313-321.
17. LeJambre, L. F. 1992. Molecular biology and anthelmintic resistance in parasitic nematodes. In "Resistance of Parasites to Antiparasitic Drugs" (J. C. Boray, P. J. Martin, and R. T. Roush, Eds.), pp. 155-164. SMD Agvet, Rahway, NJ.
18. Minchella, D. J., Lewis, F. A., Sollenberger, K. M., and Williams, J. A. 1994. Genetic diversity of Schistosoma mansoni: quantifying strain heterogeneity using a polymorphic DNA element.
19. Metwally, A., Bennett, J. L., Botros, S., Ebeid, F., and El-Attar, G. 1995. Impact of drug dosage and brand on bioavailability and efficacy of proziquantel. Pharmacology Research 31, 53-59.
20. Michelson, M. K., Axxis, F. A., Gamil, F. M., and Spencer, H. C. 1993. Recent trends in the prevalence and distribution of schistosomiasis in the Nile delta region. American Journal Tropical Medicine and Hygiene 49(1), 76-87.
21. Pax, R., Bennett, J. L., and Fetterer, R. 1979. A benzodiazepine derivative and praziquantel: Effects on musculature of S. mansoni and S. japonicum. Naunyn-Schmiedeberg's Archives Pharmacology 304, 309-314.
22. Rodger, S. H., and Bueding, E. 1971. Resistance to hycanthone: Development in Schistosoma mansoni. Science 172, 1057-1058.
23. Roos, M. H., Kwa, M. S. G., Veenstra, J. G., Kooyman, F. N. J., and Boersema, J. 1993. Molecular aspects of drug resistance in parasitic helminths. Pharmacology and Therapeutics 60, 331-345.
24. Waller, P. J. 1993. Control strategies to prevent resistance. Veterinary Parasitology 46, 133-142.
25. Waller, P. J. 1994. The development of anthelmintic resistance in ruminant livestock. Acta Tropical 56, 223-243.